Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The source introductory threshold is rendered =60; the source table is preserved separately. This is not a newly verified label transcription.
Check source scope before reading a dose
UCSF cefepime - dated institutional recheck
Product / population
Single-agent intravenous cefepime in adults. Label-mirror schedules and UCSF institutional regimens must retain their distinct context.
Renal method
CrCl in mL/min; equation not specified on the selected UCSF page
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-10
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
Daily post-HD timing is not the same as post-HD-only dosing
Label and institutional sources include daily dosing and post-dialysis-only schedules. Their indication, dialysis frequency, infusion, and exposure assumptions differ.
What to reconcile: Select one complete locally approved regimen; do not add a daily dose on top of a post-HD-only schedule.
Source difference identified; final patient-specific adjudication required.
UCSF Infectious Diseases Management Program · Single-agent intravenous cefepime in adults. Label-mirror schedules and UCSF institutional regimens must retain their distinct context.
Renal method: CrCl in mL/min; equation not specified on the selected UCSF page Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-10
Professional guidance with defined scope. Publication date, institutional setting and source limitations remain controlling. This is not automatic preference over another source.
Dialysis evidence: A regimen is reported in selected content
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
UCSF prefers short infusion. For selected patients with specialist/pharmacy recommendation, its extended-infusion maintenance is 2 g every 8 hours at CrCl >60 or every 12 hours at 30-60, infused over 4 hours; below 30 it directs use of short infusion. Loading is 2 g over 30 minutes unless already receiving short-infusion cefepime; maintenance starts four hours later. Meningitis data are limited.
For intermittent HD it lists 2 g initially and post-HD; an unstable-schedule alternative is 1 g initially then each evening. These are institutional regimens, not a manufacturer-label replacement or a universal dialysis schedule.
Selected sections only; not a complete prescribing monograph or independent clinician approval.
Named institutional guidance, not manufacturer labeling or a universal dosing recommendation. Apply only after local specialist review of patient and treatment context.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.